Abstract
Tranexamic administration to patients with traumatic bleeding is associated with decreased mortality (NNT 48) and thrombotic events (NNT 167), irrespective of injury severity.
Level of evidence: 1B
You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Select search scope: search across all journals or within the current journal
Tranexamic administration to patients with traumatic bleeding is associated with decreased mortality (NNT 48) and thrombotic events (NNT 167), irrespective of injury severity.
Level of evidence: 1B